DKK1 and metastatic neoplasm: This finding may indicate that absence of Wnt pathway inhibition by DKK-1 promotes oncogenesis, an idea supported by previous data showing that modulators of bone turnover can be altered not only in metastatic disease but also during early stages of tumor progression [7, 13].